New Jersey Assembly Bill A1889

New Jersey 2022-2023 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22

Caption

Prohibits health insurance carriers from denying payment for preauthorized covered services except under certain circumstances.

Impact

If enacted, A1889 would significantly influence how health insurance companies operate regarding payment and claims. It reinforces consumer rights by mandating that once approval for a service is granted, it cannot subsequently be revoked based on medical necessity, thereby reducing administrative barriers patients face in accessing needed care. This law would amend the existing 'Health Care Quality Act', which could lead to a more straightforward and equitable reimbursement process for both the insured and healthcare providers. The potential increase in claims paid by insurers might also encourage better health outcomes through improved access to necessary treatments.

Summary

Assembly Bill A1889 seeks to restrict health insurance carriers from denying payment for preauthorized covered services unless specific exceptions apply. This legislation aims to enhance consumer protections in health insurance by ensuring that once a service has been preauthorized, insurers cannot later deny reimbursement based on medical necessity. The bill reflects a growing concern over insurance practices that can delay or deny necessary healthcare services for patients who have adhered to the authorization processes set forth by their providers. By limiting grounds for denial to instances where services were not provided, claims were not submitted timely, or cases of fraud exist, A1889 highlights the need to ensure that health insurance adheres to a fairer process for claim approvals.

Contention

Debate surrounding A1889 may center on the implications of tightening regulation on insurance companies and how it affects their operational flexibility. While supporters may argue that this bill improves patient care and rights, critics could contend that it limits the ability of health insurers to assess the appropriate medical necessity of claims, potentially leading to increased costs for the insurance industry. Additionally, questions about the administrative capacity of insurers to manage these changes and the potential for increased premiums could be significant points of contention during discussions within legislative bodies.